DEHP/PVC
This article was originally published in The Gray Sheet
Executive Summary
Tubing and storage bags used to administer lipophilic drugs are among devices that should not contain DEHP, according to Health Canada Expert Advisory Panel report released Jan. 11. The report recommends that providers not use DEHP-containing PVC devices in the treatment of pregnant women, breastfeeding mothers, infants, males before puberty and patients undergoing cardiac bypass, hemodialysis or heart transplant surgery. Experts advocate further research into heparin-coated tubing and other alternative devices. The report follows a September 2001 FDA safety assessment on DEHP calling for investigation of alternatives to the plasticizer (1"The Gray Sheet" Sept. 10, 2001, p. 15)...